Kristen P Tamura, MD
Nephrology · Wailuku
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 2 carriers
- Office
- 1
Offices
1 location
Hospitals listed: 122510 · Maui Memorial Medical Center. That is not proof they admit you there this week.
Plans that list them
7 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tamura’s office at (808) 442-5700 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A114723 · Current
Licensed to practise in California · since 2010 · expires 2028-11-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Maui Memorial Medical CenterWailuku, HIAcute Care Hospital · Government - State · No emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 63% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.245, Oct 2024 – Sep 2025
See every measure and the patient survey for Maui Memorial Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 2 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 1 better, 6 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.245 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.48 (0.44 to 2.51) · 496 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.17 (0.76 to 1.59) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.23 (134.97 to 247.49) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.2 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.9 · 230 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 2,019 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.11 (1.73 to 6.49) · 523 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.33) · 91 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (0.43 to 3.68) · 486 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.87) · 97 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.9 (0.7 to 9.1) · 92 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 134 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.33 (0.41 to 2.24) · 2,156 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.286 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.57 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.305 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.177 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 149 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 11.8 · 75 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.8 · 153 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1.8 · 213 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 480 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (4.5 to 9.6) · 72 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.1 (6.4 to 12.6) · 72 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 114 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 16.9) · 390 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 121 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,407 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$112,764
Medicare paid this office $112,764 for 251 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Home dialysis services per month (20 years or older) | 14 | $24,409 | $207 |
| Return visit (30+ min) | 118 | $23,598 | $94 |
| Short return visit (20+ min) | 85 | $7,731 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $6,920 | $88 |
| Critical care, first 30-74 minutes | 19 | $6,676 | $152 |
See all 13 services
| Home dialysis services per month (20 years or older) | 14 | $24,409 | $207 |
| Return visit (30+ min) | 118 | $23,598 | $94 |
| Short return visit (20+ min) | 85 | $7,731 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $6,920 | $88 |
| Critical care, first 30-74 minutes | 19 | $6,676 | $152 |
| Hemodialysis procedure with physician evaluation | 30 | $5,326 | $52 |
| New patient visit (45+ min) | 35 | $4,244 | $121 |
| Long return visit (40+ min) | 16 | $3,486 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,390 | $58 |
| Transitional care management services for problem of high complexity | 12 | $3,076 | $220 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,098 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,928 | $129 |
| New patient visit (30+ min) | 12 | $1,036 | $86 |
Who their Medicare patients are
251 Original Medicare patients in 2024. Average age 75 · Under 65 12% · 85 and older 18% · Women 40% · Also on Medicaid 14% · Health risk score 2.78. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 65% · Coronary heart disease 44% · Heart failure 35% · Atrial fibrillation 27% · Cancer 19% · COPD 18% · Depression 9% · Dementia 9% · Stroke 9%.
The office billed $339,776, Medicare allowed $147,934 and paid $112,764; for 1,011 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 251 | 1,011 | 75 | 2.78 | $339,776 | $112,764 |
| 2023 | 256 | 951 | 74 | 3.10 | $311,897 | $101,875 |
| 2022 | 228 | 919 | 74 | 2.90 | $313,539 | $96,815 |
| 2021 | 225 | 783 | 73 | 3.42 | $228,098 | $84,412 |
| 2020 | 213 | 1,031 | 70 | 4.22 | $182,620 | $88,840 |
| 2019 | 237 | 928 | 75 | 4.90 | $177,468 | $95,428 |
| 2018 | 258 | 1,370 | 78 | 4.58 | $217,825 | $152,191 |
| 2017 | 305 | 1,264 | 76 | 5.03 | $217,802 | $137,776 |
| 2016 | 44 | 134 | 77 | 3.86 | $23,496 | $13,017 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Home dialysis services per month (20 years or older) | 13 | $19,388 | $215 |
| Return visit (30+ min) | 91 | $16,830 | $100 |
| Short return visit (20+ min) | 113 | $10,991 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $6,896 | $88 |
| Hemodialysis procedure with physician evaluation | 42 | $5,236 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $5,092 | $61 |
| New patient visit (45+ min) | 33 | $4,285 | $130 |
| Critical care, first 30-74 minutes | 12 | $4,037 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,421 | $127 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,712 | $101 |
| New patient visit (30+ min) | 15 | $1,394 | $93 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,054 | $66 |
2022: 11 services
| Return visit (30+ min) | 76 | $14,859 | $97 |
| Short return visit (20+ min) | 110 | $12,463 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $6,114 | $57 |
| Critical care, first 30-74 minutes | 16 | $5,713 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,672 | $75 |
| Hemodialysis procedure with physician evaluation | 32 | $4,265 | $59 |
| New patient visit (45+ min) | 23 | $3,087 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,898 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,204 | $105 |
| New patient visit (30+ min) | 24 | $2,117 | $88 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $626 | $42 |
2021: 12 services
| Return visit (30+ min) | 69 | $13,095 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $8,093 | $84 |
| Hemodialysis procedure with physician evaluation | 39 | $6,114 | $59 |
| Return visit (30+ min) | 54 | $5,070 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,764 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,970 | $59 |
| New patient visit (45+ min) | 25 | $3,568 | $143 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,128 | $106 |
| Short return visit (20+ min) | 21 | $1,667 | $72 |
| New patient visit (30+ min) | 15 | $1,360 | $91 |
| New patient visit (45+ min) | 11 | $825 | $75 |
| New patient visit (30+ min) | 11 | $361 | $33 |
2020: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $16,196 | $86 |
| Hemodialysis procedure with physician evaluation | 66 | $13,831 | $61 |
| Return visit (30+ min) | 75 | $8,398 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,977 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $6,929 | $60 |
| New patient visit (45+ min) | 48 | $4,735 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,762 | $114 |
| Hemodialysis procedure requiring repeated evaluation | 22 | $2,431 | $87 |
| Return visit (30+ min) | 11 | $991 | $66 |
| Short return visit (20+ min) | 24 | $956 | $38 |
2019: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 122 | $40,475 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $12,090 | $178 |
| Hemodialysis procedure with physician evaluation | 43 | $6,900 | $61 |
| Return visit (30+ min) | 32 | $6,069 | $103 |
| New patient visit (45+ min) | 34 | $3,592 | $106 |
| Return visit (30+ min) | 23 | $1,879 | $65 |
| New patient visit (45+ min) | 12 | $1,833 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,790 | $60 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 194 | $89,875 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $26,963 | $181 |
| Return visit (30+ min) | 38 | $7,139 | $101 |
| New patient visit (45+ min) | 18 | $2,756 | $153 |
| Hemodialysis procedure with physician evaluation | 30 | $2,078 | $65 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,975 | $99 |
2017: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 246 | $72,360 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 162 | $31,323 | $174 |
| Critical care, first 30-74 minutes | 12 | $15,898 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $4,078 | $61 |
| Hemodialysis procedure with physician evaluation | 37 | $2,384 | $63 |
| Return visit (30+ min) | 15 | $2,093 | $100 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,720 | $96 |
| Dialysis procedure including 1 evaluation | 11 | $903 | $75 |
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $7,328 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,524 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $898 | $60 |
Medicaid work
$22,212 in 2024
Medicaid paid $22,212 for 192 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 140 | $18,904 |
| Return visit (30+ min) | 28 | $2,016 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 24 | $1,292 |
| 2024 | 192 | 3 | 17 | $22,212 |
| 2023 | 74 | 3 | 16 | $5,047 |
| 2022 | 44 | 2 | 17 | $2,236 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 26 | $2,593 |
| Return visit (30+ min) | 33 | $1,840 |
| Short return visit (20+ min) | 15 | $613 |
2022
| Return visit (30+ min) | 32 | $1,772 |
| Short return visit (20+ min) | 12 | $464 |
Drugs they prescribed that Part D paid
$439,957
Pharmacies billed $439,957 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,145) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,880 generic and 265 brand-name prescriptions · $439,957 in drug cost · 58 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Kerendia | 83 | $98,610 | $1,188 |
| Farxiga | 52 | $66,518 | $1,279 |
| Jardiance | 40 | $52,796 | $1,320 |
| Auryxia | 14 | $25,116 | $1,794 |
| Sevelamer Carbonate | 55 | $19,565 | $356 |
See all 40 drugs
| Kerendia | 83 | $98,610 | $1,188 |
| Farxiga | 52 | $66,518 | $1,279 |
| Jardiance | 40 | $52,796 | $1,320 |
| Auryxia | 14 | $25,116 | $1,794 |
| Sevelamer Carbonate | 55 | $19,565 | $356 |
| Lanthanum Carbonate | 19 | $10,571 | $556 |
| Calcium Acetate | 83 | $8,897 | $107 |
| Dapagliflozin | 12 | $6,088 | $507 |
| Sps | 12 | $5,068 | $422 |
| Irbesartan | 162 | $3,809 | $24 |
| Torsemide | 80 | $3,020 | $38 |
| Metoprolol | 94 | $1,752 | $19 |
| Hydralazine | 87 | $1,429 | $16 |
| Amlodipine Besylate | 133 | $1,345 | $10 |
| Carvedilol | 140 | $1,149 | $8 |
| Allopurinol | 117 | $1,146 | $10 |
| Nifedipine Er | 28 | $1,142 | $41 |
| Doxazosin Mesylate | 43 | $1,069 | $25 |
| Bumetanide | 13 | $1,053 | $81 |
| Calcitriol | 54 | $953 | $18 |
| Diltiazem 24hr Er (Cd) | 28 | $946 | $34 |
| Colchicine | 13 | $911 | $70 |
| Lisinopril | 72 | $884 | $12 |
| Midodrine | 17 | $874 | $51 |
| Losartan | 67 | $843 | $13 |
| Potassium Chloride | 25 | $798 | $32 |
| Furosemide | 121 | $791 | $7 |
| Felodipine Er | 21 | $548 | $26 |
| Tamsulosin | 22 | $508 | $23 |
| Isosorbide Mononitrate Er | 21 | $452 | $22 |
| Spironolactone | 19 | $397 | $21 |
| Metolazone | 19 | $384 | $20 |
| Gentamicin Sulfate | 27 | $296 | $11 |
| Hydroxyzine | 12 | $244 | $20 |
| Clonidine | 18 | $164 | $9 |
| Atorvastatin | 12 | $147 | $12 |
| Cephalexin | 25 | $146 | $6 |
| Lactulose | 12 | $141 | $12 |
| Hydrochlorothiazide | 23 | $127 | $6 |
| Prednisone | 11 | $77 | $7 |
Year by year
| 2024 | 2,145 | 305 | 0% (0) | 12% | $439,957 |
| 2023 | 1,813 | 253 | 0% (0) | 13% | $384,433 |
| 2022 | 1,342 | 203 | 0% (0) | 12% | $231,186 |
| 2021 | 934 | 162 | 0% (0) | 15% | $130,304 |
| 2020 | 615 | 122 | 0% (0) | 22% | $99,825 |
| 2019 | 526 | 84 | 0% (0) | None | $54,094 |
| 2018 | 452 | 58 | None | None | $59,454 |
| 2017 | 265 | 93 | None | None | $34,366 |
| 2016 | 426 | 133 | None | 17% | $26,664 |
| 2015 | 178 | 68 | None | 18% | $4,985 |
| 2014 | 267 | 137 | None | 22% | $10,426 |
| 2013 | 369 | 210 | 8% (28) | None | $13,106 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Velphoro | 12 | $74,863 | $6,239 |
| Farxiga | 56 | $59,869 | $1,069 |
| Kerendia | 40 | $52,070 | $1,302 |
| Jardiance | 28 | $39,966 | $1,427 |
| Auryxia | 11 | $24,151 | $2,196 |
| Sevelamer Carbonate | 42 | $20,787 | $495 |
| Lokelma | 14 | $20,769 | $1,484 |
| Veltassa | 12 | $16,378 | $1,365 |
| Calcium Acetate | 41 | $4,454 | $109 |
| Hydralazine | 119 | $2,714 | $23 |
| Bumetanide | 27 | $2,498 | $93 |
| Diltiazem 24hr Er (Cd) | 43 | $2,334 | $54 |
| Torsemide | 68 | $2,317 | $34 |
| Metoprolol | 94 | $2,176 | $23 |
| Losartan | 76 | $2,066 | $27 |
| Nifedipine Er | 28 | $1,900 | $68 |
| Irbesartan | 67 | $1,623 | $24 |
| Amlodipine Besylate | 93 | $1,591 | $17 |
| Allopurinol | 89 | $1,459 | $16 |
| Carvedilol | 118 | $1,450 | $12 |
| Calcitriol | 69 | $1,432 | $21 |
| Metolazone | 20 | $1,302 | $65 |
| Doxazosin Mesylate | 55 | $1,211 | $22 |
| Furosemide | 109 | $1,080 | $10 |
| Felodipine Er | 26 | $1,026 | $39 |
| Potassium Chloride | 21 | $919 | $44 |
| Lisinopril | 70 | $749 | $11 |
| Isosorbide Mononitrate Er | 21 | $546 | $26 |
| Tamsulosin | 30 | $512 | $17 |
| Klor-Con 10 | 11 | $488 | $44 |
| Finasteride | 15 | $216 | $14 |
| Atorvastatin | 13 | $151 | $12 |
| Cephalexin | 13 | $87 | $7 |
| Hydrochlorothiazide | 17 | $65 | $4 |
2022: 32 drugs
| Velphoro | 11 | $53,244 | $4,840 |
| Sevelamer Carbonate | 50 | $30,565 | $611 |
| Aranesp | 16 | $26,229 | $1,639 |
| Auryxia | 12 | $20,584 | $1,715 |
| Lokelma | 23 | $17,483 | $760 |
| Farxiga | 17 | $13,359 | $786 |
| Calcium Acetate | 37 | $4,654 | $126 |
| Metolazone | 30 | $2,591 | $86 |
| Hydralazine | 101 | $1,922 | $19 |
| Bumetanide | 17 | $1,763 | $104 |
| Calcitriol | 69 | $1,503 | $22 |
| Torsemide | 40 | $1,213 | $30 |
| Losartan | 76 | $1,154 | $15 |
| Carvedilol | 100 | $1,101 | $11 |
| Nifedipine Er | 18 | $1,033 | $57 |
| Metoprolol | 37 | $989 | $27 |
| Eplerenone | 11 | $839 | $76 |
| Diltiazem 24hr Er (Cd) | 27 | $832 | $31 |
| Doxazosin Mesylate | 31 | $795 | $26 |
| Furosemide | 107 | $765 | $7 |
| Allopurinol | 47 | $726 | $15 |
| Amlodipine Besylate | 94 | $660 | $7 |
| Tamsulosin | 23 | $469 | $20 |
| Felodipine Er | 11 | $364 | $33 |
| Lisinopril | 51 | $300 | $6 |
| Potassium Chloride | 16 | $284 | $18 |
| Isosorbide Mononitrate Er | 11 | $229 | $21 |
| Irbesartan | 14 | $160 | $11 |
| Gentamicin Sulfate | 11 | $121 | $11 |
| Cephalexin | 19 | $86 | $5 |
| Hydrochlorothiazide | 11 | $75 | $7 |
| Spironolactone | 11 | $69 | $6 |
2021: 24 drugs
| Aranesp | 16 | $21,014 | $1,313 |
| Sevelamer Carbonate | 41 | $15,124 | $369 |
| Lokelma | 21 | $14,627 | $697 |
| Calcium Acetate | 39 | $6,150 | $158 |
| Febuxostat | 11 | $1,964 | $179 |
| Calcitriol | 51 | $1,724 | $34 |
| Hydralazine | 85 | $1,462 | $17 |
| Nifedipine Er | 15 | $1,159 | $77 |
| Metolazone | 19 | $1,101 | $58 |
| Carvedilol | 76 | $930 | $12 |
| Allopurinol | 31 | $599 | $19 |
| Losartan | 52 | $595 | $11 |
| Furosemide | 75 | $514 | $7 |
| Doxazosin Mesylate | 22 | $498 | $23 |
| Metoprolol | 22 | $479 | $22 |
| Torsemide | 20 | $417 | $21 |
| Tamsulosin | 20 | $312 | $16 |
| Potassium Chloride | 12 | $292 | $24 |
| Irbesartan | 16 | $280 | $17 |
| Lisinopril | 47 | $269 | $6 |
| Amlodipine Besylate | 48 | $262 | $5 |
| Gentamicin Sulfate | 12 | $108 | $9 |
| Ciprofloxacin | 12 | $55 | $5 |
| Cephalexin | 12 | $53 | $4 |
2020: 17 drugs
| Lokelma | 22 | $16,716 | $760 |
| Sevelamer Carbonate | 15 | $12,967 | $864 |
| Jardiance | 12 | $8,391 | $699 |
| Calcium Acetate | 28 | $3,379 | $121 |
| Labetalol | 15 | $1,629 | $109 |
| Calcitriol | 50 | $1,576 | $32 |
| Nifedipine Er | 21 | $969 | $46 |
| Hydralazine | 49 | $876 | $18 |
| Torsemide | 11 | $509 | $46 |
| Carvedilol | 38 | $477 | $13 |
| Allopurinol | 24 | $424 | $18 |
| Losartan | 30 | $387 | $13 |
| Metoprolol | 13 | $324 | $25 |
| Tamsulosin | 18 | $323 | $18 |
| Amlodipine Besylate | 51 | $273 | $5 |
| Furosemide | 46 | $230 | $5 |
| Lisinopril | 20 | $131 | $7 |
2019: 13 drugs
| Sevelamer Carbonate | 12 | $5,020 | $418 |
| Calcium Acetate | 38 | $2,902 | $76 |
| Metolazone | 14 | $2,154 | $154 |
| Furosemide | 87 | $831 | $10 |
| Labetalol | 25 | $808 | $32 |
| Hydralazine | 19 | $489 | $26 |
| Calcitriol | 15 | $404 | $27 |
| Carvedilol | 50 | $370 | $7 |
| Allopurinol | 30 | $265 | $9 |
| Atorvastatin | 11 | $259 | $24 |
| Amlodipine Besylate | 32 | $154 | $5 |
| Lisinopril | 23 | $101 | $4 |
| Losartan | 16 | $98 | $6 |
2018: 12 drugs
| Renvela | 15 | $20,841 | $1,389 |
| Calcium Acetate | 31 | $1,972 | $64 |
| Metolazone | 13 | $1,200 | $92 |
| Calcitriol | 22 | $586 | $27 |
| Hydralazine | 20 | $350 | $17 |
| Losartan | 43 | $309 | $7 |
| Furosemide | 67 | $294 | $4 |
| Carvedilol | 34 | $240 | $7 |
| Atorvastatin | 15 | $197 | $13 |
| Lisinopril | 14 | $143 | $10 |
| Metoprolol | 19 | $126 | $7 |
| Amlodipine Besylate | 18 | $97 | $5 |
2017: 5 drugs
| Veltassa | 11 | $7,709 | $701 |
| Furosemide | 20 | $94 | $5 |
| Losartan | 17 | $79 | $5 |
| Metoprolol | 17 | $70 | $4 |
| Amlodipine Besylate | 13 | $52 | $4 |
2016: 9 drugs
| Ventolin Hfa | 14 | $530 | $38 |
| Calcitriol | 22 | $491 | $22 |
| Amlodipine Besylate | 21 | $239 | $11 |
| Losartan | 28 | $228 | $8 |
| Furosemide | 44 | $201 | $5 |
| Metoprolol | 27 | $173 | $6 |
| Ciprofloxacin | 12 | $129 | $11 |
| Lisinopril | 14 | $102 | $7 |
| Torsemide | 12 | $62 | $5 |
2015: 3 drugs
| Calcitriol | 17 | $254 | $15 |
| Lisinopril | 12 | $107 | $9 |
| Amlodipine Besylate | 13 | $82 | $6 |
2014: 4 drugs
| Qvar | 23 | $1,740 | $76 |
| Proair Hfa | 17 | $549 | $32 |
| Fluticasone Propionate | 20 | $440 | $22 |
| Nabumetone | 13 | $222 | $17 |
2013: 6 drugs
| Proair Hfa | 25 | $885 | $35 |
| Fluticasone Propionate | 31 | $685 | $22 |
| Nabumetone | 11 | $349 | $32 |
| Hydrocodone-Acetaminophen | 17 | $197 | $12 |
| Azithromycin | 18 | $191 | $11 |
| Prednisone | 11 | $74 | $7 |
Money from drug and device companies
$689 in 2025
| 2025 | 7 | 24 | None | $689 |
| 2024 | 5 | 27 | None | $680 |
| 2023 | 3 | 21 | $4,900 | $8,706 |
| 2022 | 3 | 5 | None | $294 |
| 2021 | 2 | 6 | None | $433 |
| 2019 | 2 | 2 | None | $117 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bayer Healthcare Pharmaceuticals | Kerendia | $324 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $117 | 1 payment
|
| Ardelyx | Ibsrela | $79 | 4 payments
|
| Travere Therapeutics | None | $68 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $52 | 2 payments
|
| Gilead Sciences | None | $30 | 1 payment
|
See all 24 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-12 | Kerendia | $21 |
| Ardelyx | Meals · 2025-12-10 | Ibsrela | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-20 | Kerendia | $21 |
| Travere Therapeutics | Meals · 2025-11-13 | None | $35 |
| Ardelyx | Meals · 2025-11-11 | Ibsrela | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-29 | Kerendia | $6 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-23 | Kerendia | $20 |
| Calliditas Therapeutics US | Meals · 2025-09-24 | Tarpeyo | $36 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-18 | Kerendia | $21 |
| Travere Therapeutics | Meals · 2025-08-27 | None | $33 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-21 | Kerendia | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-13 | Kerendia | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-31 | Saphnelo | $117 |
| Ardelyx | Meals · 2025-07-30 | Ibsrela | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-16 | Kerendia | $17 |
| Ardelyx | Meals · 2025-06-24 | Ibsrela | $22 |
| Gilead Sciences | Meals · 2025-06-18 | None | $30 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-21 | Kerendia | $20 |
| Amgen | Meals · 2025-05-08 | Krystexxa | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-29 | Kerendia | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-23 | Kerendia | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-01 | Kerendia | $95 |
| Calliditas Therapeutics US | Meals · 2025-03-03 | Tarpeyo | $15 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-26 | Kerendia | $25 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $680
| Bayer Healthcare Pharmaceuticals | Kerendia | $239 | 15 payments
|
| Travere Therapeutics | None | $192 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $120 | 1 payment
|
| Ardelyx | Ibsrela | $107 | 6 payments
|
| Merck Sharp & Dohme | Winrevair | $22 | 1 payment
|
2023: $8,706
| Outset Medical | None | $8,454 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $184 | 13 payments
|
| Travere Therapeutics | None | $68 | 4 payments
|
2022: $294
| Bayer HealthCare Pharmaceuticals | Kerendia | $152 | 3 payments
|
| Outset Medical | None | $122 | 1 payment
|
| Amgen | Tavneos | $20 | 1 payment
|
2021: $433
| NxStage Medical | Nxstage System One | $309 | 5 payments
|
| Outset Medical | None | $124 | 1 payment
|
2019: $117
| Baxter Healthcare | Renal - Pd | $100 | 1 payment
|
| Relypsa | Veltassa | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1356502553
- Licence
- CA A114723, HI MD19906California A114723: Current · expires 2028-11-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 85 Maui Lani Pkwy, Wailuku, HI, 96793
- NPI first listed
- 2008-06-19
- NPI last updated
- 2021-05-04
- NPI record certified
- 2021-05-04
This is when the NPI record was last certified, not a medical board exam.